DANOS OLIVIER (Chief Scientific Officer) reported 1 transaction at REGENXBIO INC.
Review the transaction codes below to understand the nature of each event.
Filed: 4/4/2025ACC: 0001562180-25-003008
Officer· Chief Scientific Officer
Since Oct 2018
-5.45K
Net shares
Net seller
$44.0K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
5.45K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−5.45K
Price / share
$8.07
Trade value
$44K
% of position
2.4%
2/1/2025
231.80K→226.35K
Total
Net shares
−5.45K
Net value
-$44K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/1/2025 | F · Tax Withholding | −5.45K | $8.07 | $44K | 2.4% | 231.80K | 226.35K |
| Total | −5.45K | -$44K | ||||||
Derivative Transactions0
No derivative transactions reported